KUKJEON PHARMACEUTICAL Co., Ltd (KOSDAQ:307750)

South Korea flag South Korea · Delayed Price · Currency is KRW
4,145.00
+955.00 (29.94%)
At close: Feb 27, 2026
18.43%
Market Cap 207.98B
Revenue (ttm) 132.97B
Net Income (ttm) -3.62B
Shares Out 50.18M
EPS (ttm) -82.99
PE Ratio n/a
Forward PE n/a
Dividend 10.00 (0.24%)
Ex-Dividend Date n/a
Volume 7,720,998
Average Volume 502,336
Open 3,250.00
Previous Close 3,190.00
Day's Range 3,210.00 - 4,145.00
52-Week Range 2,780.00 - 5,290.00
Beta -0.83
RSI 79.94
Earnings Date Feb 27, 2026

About KUKJEON PHARMACEUTICAL

KUKJEON PHARMACEUTICAL Co., Ltd operates as a chemical total solutions provider in South Korea. It provides various chemical-based products and services; and after-sales services, such as research and development, production, quality control, and DMF services. The company manufactures active pharmaceutical ingredients; and offers molecular design and technical support. It develops electronic materials, such as antistatic agents, monomers and polymers with low dielectric constant, and UV curing agents; low-resistance electrolyte, phosphine, sila... [Read more]

Industry Medicinal Chemicals and Botanical Products
Founded 1972
Employees 178
Stock Exchange KOSDAQ
Ticker Symbol 307750
Full Company Profile

Financial Performance

In 2024, KUKJEON PHARMACEUTICAL's revenue was 136.47 billion, an increase of 11.86% compared to the previous year's 122.00 billion. Earnings were 1.74 billion, a decrease of -64.01%.

Financial Statements

News

There is no news available yet.